List view / Grid view

Arun Narayan (Medicines for Europe)

 

article

Achieving sustainable innovation with value-added medicines

The COVID-19 pandemic spotlighted drug repurposing as a key strategy…

26 August 2021 | By

The COVID-19 pandemic spotlighted drug repurposing as a key strategy to support traditional novel chemical entity development; yet repurposing is just one example of how off-patent molecules can be further developed to provide patients with more treatment options. Here, Arun Narayan, Chairman of the Value Added Medicines Sector Group at…